Autopsy report · NCT05410301

Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma

“PI leaving institution”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Varun Monga, MD

Sponsor type

University, hospital or other

Conditions

Glioblastoma; Recurrent Glioblastoma

Interventions

Static Magnetic and Electric (sBE) device; Lomustine; Bevacizumab

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• A Zero Acute Kidney Injury Strategy for Percutaneous Coronary Intervention in Patients With ChronicKidney Disease
  “The PI is leaving the institution” (94% match in meaning)
• Attention Modulation for Treatment of Parkinson's Disease and Dementia With Lewy Bodies
  “PI departure from institution” (94% match in meaning)
• Hemodynamic Effects Of Impella On Renal Circulation And Risk Of CA-AKI Among Patients Undergoing Protected PCI
  “PI may be leaving the institution” (93% match in meaning)
• PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer
  “Due to PI leaving the institution” (93% match in meaning)
• Growth Hormone and Exclusion Diet Therapy in Juvenile Crohn's Disease
  “PI left the institution” (92% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.